Adamas Pharmaceuticals Expands Its Phase 3 Program With ADS-5102 for the Treatment of Levodopa-induced Dyskinesia (LID ...

finance.yahoo.com/news/adamas-pharmaceuticals-expands-phase-3-200100032.html

EMERYVILLE, Calif. -- Adamas Pharmaceuticals, Inc. today announced that it has initiated an additional Phase 3 safety and efficacy study evaluating ADS-5102 for the treatment of...

Parkinson's Drugs May Spur Compulsive Behaviors

www.medicinenet.com/guide.asp?s=rss&k=DailyHealth&a=184739

Title: Parkinson's Drugs May Spur Compulsive Behaviors Category: Health News Created: 10/20/2014 12:00:00 AM Last Editorial Review: 10/21/2014 12:00:00 AM

Parkinson's patients re-learning the joy of dance

ca.news.yahoo.com/parkinsons-patients-learning-joy-dance-160136068.html

A group of people who have been diagnosed with Parkinson' s disease took part in a special workshop on Monday to get their bodies moving again. Canada's National Ballet School held...

Parkinson's Drugs Can Be A Gateway To Sin

www.npr.org/blogs/health/2014/10/20/357586341/parkinsons-drugs-can-be-a-gateway-to-sin?utm_medium=RSS&utm_campaign=news

Researchers call for stronger safety warnings on drugs called dopamine agonists because they can trigger self-destructive, obsessional behavior in some people.

OhioHealth Delay the Disease Parkinson's Program Gets Participants Moving Again

ca.finance.yahoo.com/news/ohiohealth-delay-disease-parkinsons-program-182300410.html

COLUMBUS, Ohio, Oct. 15, 2014 /PRNewswire/ -- OhioHealth "Delay the Disease", an evidenced-based fitness program designed for people with Parkinson' s Disease, is one of the newest...

Parkinson's disease can migrate from gut to brain, shows research

www.news-medical.net/news/20141013/Parkinsons-disease-can-migrate-from-gut-to-brain-shows-research.aspx

Parkinson' s disease is strongly linked to the degeneration of the brain's movement center. In the last decade, the question of where the disease begins has led researchers to a...

Cynapsus Therapeutics' Phase 2 Drug Candidate for Parkinson's Chosen as One of the Top Ten Neurology Projects to Watch

finance.yahoo.com/news/cynapsus-therapeutics-phase-2-drug-100000297.html

Cynapsus Therapeutics Inc. today announced that its APL-130277 for Parkinson' s was recognized as one of the Top Ten Neurology Projects to Watch by a joint selection committee...

Disputed theory on Parkinson's origin strengthened

www.eurekalert.org/pub_releases/2014-10/lu-dto101314.php

( Lund University ) In 2003, the German neuropathologist Heiko Braak presented a theory suggesting that the disease begins in the gut and spreads to the brain. The idea has since,...

From Parkinson's Researcher to Parkinson's Patient - Generously giving back to support the American Parkinson Disease ...

www.prweb.com/releases/2014/10/prweb12266669.htm

Alice Lazzarini , PhD, and internationally recognized researcher in neurogenetic disorders, announces the donation of a portion of proceeds from Both Sides Now: A Journey From...

Bayes Impact Uses Ayasdi's Advanced Analytics to Discover New Breakthroughs in Parkinson's Disease

finance.yahoo.com/news/bayes-impact-uses-ayasdis-advanced-150000825.html

Ayasdi today announced that it is teaming up with Bayes Impact to discover insights that will lead to improved outcomes for people with Parkinson' s disease. The Michael J. Fox...